SirT1通过去乙酰化MST1调控mitophagy活性在尼克酰胺核糖保护酒精性肝病中的作用及机制
批准号:
82103817
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
王素凡
依托单位:
学科分类:
人类营养
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
王素凡
中文摘要
我国酒精性肝病(ALD)患病率日益增加,但发病机制不明且无特效药。我们前期发现,尼克酰胺核糖(NR)补充可减轻ALD。酒精导致细胞总体自噬水平下降,但线粒体自噬(mitophagy)被诱导,自噬流可能被阻断;下调mitophagy受体FUNDC1,上调mitophagy的抑制剂MST1,而NR提高自噬,上调FUNDC1,下调MST1,改善线粒体结构和功能,提示NR可能激活mitophagy清除受损的线粒体,但具体机制尚不清楚。我们设想补充NR激活SirT1,抑制MST1活性,激活FUNDC1介导mitophagy,减轻ALD?本研究拟通过构建SirT1, MST1, FUNDC1敲减或过表达小鼠和细胞模型,通过多种分子生物学手段证实NR可通过抑制MST1激活mitophagy减轻ALD,以完善NR补充减轻ALD的机制,为人群应用膳食补充剂NR防治ALD提供理论基础。
英文摘要
Prevalence of ALD in Chinese adults have been sustainably increasing, of which pathogenesis is unclear and specific therapeutic drugs lack. We previously reported that NR supplementation effectively alleviated alcohol-induced liver injuries in C57BL/6J mice. Alcohol intakes decreased the whole cell autophagy, however, mitophagy was induced and autophagy flux may be blocked by alcohol. Alcohol decreased FUNDC1, a mitophagy receptor, and increased MST1, a major inhibitor controlling mitophagy activation. NR supplementation improved autophagy, increased FUNDC1 and decreased MST1, thus maintaining normal structure and function of mitochondria, suggesting that NR might activate mitophagy to eliminate the damaged mitochondria. However, the mechanism is not entirely clear. We assumed that NR supplementation inhibited MST1 via SIRT1 activation, activated FUDC1 mediating mitophagy, and cleared damaged mitochondria, thus alleviating ALD? We intend to establish the knockdown or overexpression models of SIRT1, MST1 and FMDC1, to confirm that NR can alleviate ALD by MST1 inhibition and mitophagy activation via a variety of molecular biological methods both in vivo and in vitro. We expected to provide new theoretical basis for further application of NR supplement to prevent ALD.
我国酒精性肝病(ALD)患病率日益增加,但临床治疗手段有限。尼克酰胺核糖(NR)是一种天然的水溶性维生素B3衍生物,近年来因其作为NAD+的前体高效提升NAD+水平从而对神经、心血管健康起保护作用而备受关注。我们前期发现,NR补充通过激活线粒体生物合成减轻ALD。本项目在此基础上深入研究,发现NR通过激活FUNDC1介导的线粒体自噬通路,在早期酒精性肝损伤中展现出显著的线粒体质量控制作用。其分子机制涉及通过提升NAD+激活SIRT1,稳定溶酶体膜完整性,通过FUNDC1促进受损线粒体与自噬体的特异性识别,使其通过mitophagy-lysosome融合途径进行定向清除,有效维持自噬流动态平衡。进一步研究发现,这个过程与Hippo信号通路的核心上游激酶MST1相关,NR通过促进MST1的去乙酰化从而发挥抑制MST1活性的作用,继而调控下游效应分子YAP/TAZ,影响mitophagy相关基因的表达,这一过程受SirT1的影响。NR通过mitophagy这种方式改善酒精代谢应激下的线粒体质量控制,提示其多靶点调控特性,为ALD的代谢干预提供了新的分子药理依据。
国内基金
海外基金